Abuse resistant opioid drug-ion exchange resin complexes having hybrid coatings
Patent Information
- Authority / Receiving Office
- US · United States
- Patent Type
- Applications(United States)
- Current Assignee / Owner
- TRIS PHARMA
- Publication Date
- 2012-06-14
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application is a continuation of U.S. patent application Ser. No. 12 / 154,970, filed May 28, 2008, which is an application that claims the benefit under 35 USC 119(e) of U.S. Provisional Patent Application No. 60 / 941,169, filed May 31, 2007, now expired.BACKGROUND OF THE INVENTION
[0002] Opioids are commonly prescribed because of their effective analgesic, or pain-relieving, properties. Medications that fall within this class, referred to as prescription narcotics, include morphine sulfate (e.g., Kadian®, Avinza™), codeine salts, oxycodone HCl (e.g., OxyContin™, Percodan™, Percocet™), and related drugs. For example, OxyContin™ tablets are presently commercially available in 10, 20, 40, 80, and 160 milligrams forms. Morphine, for example, is often used before and after surgical procedures to alleviate severe pain. Codeine, on the other hand, is often prescribed for mild pain. In addition to their pain-relieving properties, some of these ...